RIZZETTO, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 972
EU - Europa 317
AS - Asia 164
AF - Africa 46
SA - Sud America 5
OC - Oceania 1
Totale 1.505
Nazione #
US - Stati Uniti d'America 970
IT - Italia 94
CN - Cina 87
IE - Irlanda 83
SG - Singapore 63
SE - Svezia 59
CI - Costa d'Avorio 36
FR - Francia 29
GB - Regno Unito 25
MA - Marocco 10
FI - Finlandia 9
BE - Belgio 6
IN - India 5
RU - Federazione Russa 5
TH - Thailandia 5
CL - Cile 3
DE - Germania 3
CA - Canada 2
PT - Portogallo 2
TR - Turchia 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
KR - Corea 1
TW - Taiwan 1
Totale 1.505
Città #
Chandler 180
Des Moines 168
Ashburn 117
Boardman 99
Dublin 75
New York 56
Abidjan 36
Singapore 27
Ancona 20
Washington 20
Lawrence 16
Princeton 16
Boydton 15
Fairfield 15
Los Angeles 15
Seattle 12
Shanghai 12
San Diego 10
Helsinki 9
Rome 9
Woodbridge 9
London 8
Falls Church 7
San Mateo 7
Turin 7
Wilmington 7
Wuhan 7
Brussels 6
Guangzhou 6
Houston 6
Redmond 6
Bangkok 5
Ann Arbor 4
Beijing 4
Cambridge 4
Kilburn 4
Moscow 4
Southwark 4
Ascoli Piceno 3
Centro 3
Florence 3
Heze 3
Perugia 3
San Bernardo 3
Wuxi 3
Acton 2
Dallas 2
Falconara Marittima 2
Folignano 2
Huskvarna 2
Jinhua 2
Laurel 2
Lisbon 2
Menlo Park 2
Montelupone 2
Norwalk 2
Novara 2
Prescot 2
Pune 2
Quanzhou 2
San Benedetto del Tronto 2
Santa Clara 2
Toronto 2
Yiwu 2
Adelaide 1
Alpharetta 1
Andover 1
Bergamo 1
Bruino 1
Chengdu 1
Clifton 1
Dalian 1
Dongyang 1
Emet 1
Filottrano 1
Fremont 1
Istanbul 1
Jiaxing 1
Jinan 1
Jining 1
Monsampolo del Tronto 1
Nanjing 1
Nantong 1
New Taipei City 1
Nuremberg 1
Ramos Mejia 1
Rezh 1
Riva 1
Sant'elpidio A Mare 1
Seoul 1
Sofia 1
Somerville 1
Suzhou 1
Tiantai Chengguanzhen 1
Tolentino 1
Visakhapatnam 1
Zibo 1
Totale 1.124
Nome #
Review: A safety profile of dalbavancin for onand off-label utilization 77
The less-known face of dupilumab: its role in mesenchymal stem cells by interleukin-13 modulation 77
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 73
Oxidative stress and alterations of paraoxonases in atopic dermatitis 72
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 64
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 63
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 61
New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing. Antibiotics 58
VACCINATION AGAINST SARS-COV-2 and PSORIASIS: the three things every dermatologist should now 56
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 54
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 51
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 45
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 41
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 40
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 39
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 38
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 37
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 36
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 36
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 36
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 34
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 34
Bullous Pemphygoid and Novel Therapeutic Approaches 33
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 25
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 25
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 25
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 22
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 22
null 22
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 22
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 21
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 21
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 20
MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives 19
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 19
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 18
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 17
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review 16
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 15
CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study 15
Biological treatments for pediatric psoriasis: state of the art and future perspectives 14
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 14
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 13
Role of daptomycin in cutaneous wound healing: a narrative review 13
null 9
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study 8
New insight into old and new antimicrobial molecules targeting quorum sensing for MRSA wound infection 4
Totale 1.574
Categoria #
all - tutte 13.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 25 3
2021/2022154 10 9 1 4 16 7 2 3 13 3 47 39
2022/2023609 29 47 26 57 32 223 0 27 96 2 43 27
2023/2024513 55 9 65 65 66 123 15 41 4 24 5 41
2024/2025270 145 69 37 8 11 0 0 0 0 0 0 0
Totale 1.574